The Federal Government has confirmed the detection of the SARS-CoV-2 Delta variant, also known as lineage B.1.617.2. in the country.
This was announced by the Nigerian Centre for Disease Control (NCDC) after the Delta Covid-19 variant was detected in a traveler to Nigeria during a routine travel test mandatory for all international passengers and genomic sequencing at the NCDC laboratory in Abuja.
This announcement was disclosed in a statement issued by NCDC and signed by its Head of Communications, Dr. Yahaya Disu which partly reads as follows;
“The Nigeria Centre for Disease Control (NCDC) has detected a confirmed case with the SARS-CoV-2 Delta variant, also known as lineage B.1.617.2. The variant was detected in a traveler to Nigeria, following the routine travel test required of all international travelers and genomic sequencing at the NCDC National Reference Laboratory, Abuja.
As part of Nigeria’s COVID-19 response, NCDC has been working with the Nigerian Institute of Medical Research (NIMR), African Centre for Genomics of Infectious Diseases (ACEGID), and other laboratories within the national network, to carry out genomic sequencing.
This is to enable the detection of variants of concern and initiate response activities. All data on variants from Nigeria have been published on GISAID, a global mechanism for sharing sequencing data. Given the global risk of spread of the Delta variant, positive samples from international travellers to Nigeria are sequenced regularly.
Given the high transmissibility of the Delta variant and following its detection in Nigeria, NCDC urges all Nigerians to ensure strict adherence to public health and social measures in place. Proven public health and social measures such as physical distancing, frequent handwashing, and proper use of face masks, prevent infections and save lives. The COVID-19 vaccine is safe and effective and offers protection against the disease.”